As 2025 comes to a close, Holland & Knight antitrust and healthcare attorneys are analyzing how federal and state scrutiny of healthcare consolidation has reshaped the industry and providing intelligence on how to navigate 2026. The Federal Trade Commission (FTC) implemented significant changes to Hart-Scott-Rodino Act (HSR) filing requirements and broadened its enforcement spotlight from only private equity firms to all stakeholders in the healthcare industry. On the state level, 2025 saw heightened bipartisan scrutiny of healthcare consolidation, with a focus on the corporate practice of medicine (CPOM) and private equity investments.
Read the full article: Charting a Path Forward in 2026: Holland & Knight’s Year-End Healthcare Antitrust Report //
Source: https://www.hklaw.com/en/insights/publications/2025/12/charting-a-path-forward-in-2026-holland-knights-year-end-healthcare